Cara Therapeutics, Inc. Company Profile

20:25 EDT 22nd September 2017 | BioPortfolio

News Articles [1581 Associated News Articles listed on BioPortfolio]

Cara Therapeutics (CARA) Updates On CR845-CLIN2002 OA Phase 2b Data - Slideshow

Cara's uremic pruritus drug wins FDA breakthrough status

Cara Therapeutics' I.V.  -More- 

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q2 2017 Results - Earnings Call Transcript

Cara Therapeutics (CARA) Presents At Canaccord Genuity 37th Annual Growth Conference - Slideshow

STAT Plus: Cara Therapeutics: A lesson in clinical trial failure and spin

Cara Therapeutics tried to misdirect investors away from the failure of its osteoarthritis pain pill by burying negative results from a mid-stage clinical trial in the middle of a press…

Cara Therapeutics Stock Is Set Up for Further Gains

CARA Stock: New All-Time High Biotechnology stocks have woken up from a slumber and they are acting up, which is a nice change because this sector was lagging behind the major market indices for a ...

Today's Research Report Coverage on Biotech Stocks -- Bellicum Pharma, Cara Therapeutics, ...

If you want a Stock Review on BLCM, CARA, CERS, or CHRS then come over to sign up for your free customized report Read more...

Cara loses a third of its share price on disappointing Phase II results

Connecticut, USA-based biotech firm Cara Therapeutics has suffered a massive drop in share price after…

PubMed Articles [561 Associated PubMed Articles listed on BioPortfolio]

Effect of pasteurization on flavonoids and carotenoids in Citrus sinensis (L.) Osbeck cv. «Cara Cara» and «Bahia» juices.

Orange juice is considered an excellent dietary source of several bioactive compounds with beneficial properties for human health. Citrus sinensis Osbeck cv. "Cara Cara" is a bud mutation originated f...

Lesión cribiforme en la cara de un varón de 44 años de edad.

El acantoma de la vaina pilosa es un tumor benignode piel muy poco frecuente. Suele presentarse comouna pápula asintomática, con un orificio central y lalocalización más frecuente es la cara. Pres...

Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.

Response to Aslankurt et al. re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model".

Is the Eye an Extension of the Brain in Central Nervous System Disease?

Clinical Trials [119 Associated Clinical Trials listed on BioPortfolio]

Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric cont...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1147 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...


Cara Therapeutics, Inc.

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Cara Therapeutics, Inc." on BioPortfolio

We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record